Minireviews
Copyright ©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 106618
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.106618
Table 2 Outcomes of patients with anti-tuberculosis drug-induced acute liver failure
Ref.
AT-ALF
(n)
Demographic features
ATD-ALF interval
LT, n (%)
Post-LT survival (%)
Mortality (%)
Ichai et al[28], 20101404 (28.5%) male, 10 (71.5%) female, median age – 37 years3.5 ± 3.1 months6 (42.8)5028.5
Kumar et al[19], 20107021 (30%) male, 49 (70%) female, mean age 328 years30 (7-350) daysNone-67.1
Idilman et al[11], 2006
1Female, 19 years3 days1 (100)100None
Mindikoglu et al[29], 20095032 (64%) female, 18 (36%) male
-50 (100)8218
Bavikatte et al[67], 2017703 (42.8%) male, 04 (57.2%) female, median age – 32 (5-39) years2 months7 (100)71.428
Huh et al[52], 20171910 (52.6%) male, 9 (47.4%) female, mean age – 46 years61 (40-113) days6 (31.5)10052.6
Li et al[39], 2018
1Male, 67 years77 days1 (100)0100
Martino et al[49], 2018808 (100%) female, median age – 39 (17-56) years21 to 155 days8 (100)5050
Bartoletti et al[63], 20172614 (54%) male, 12 (46%) female, median age – 38 (25-50) years-26 (100)8515
Wang et al[27], 20205534 (61.8%) male, 21 (39.2%) female, mean age 50.3 ± 15.9 years51 (7-330 days)None-9.68
Smink et al[65], 2006201 male and 01 female139.5 days2 (100)2 (100)None
Zhu et al[66], 20211Female, 26 years3 days1 (100)100None
Farrell et al[46], 1994249 years male and 60 years female4 months and 6 weeks2 (100)100None
Barcena et al[47], 20051Male, 39 years1 month1 (100)100None
Pessayre et al[12], 1977601 (17%) male, 05 (83%) female, mean age – 46 ± 24 years7.3 ± 1.8 days 0-None
Mitchell et al[48], 1995401 (25%) male, 03 (75%) female, mean age – 51.75 ± 13.98 3.5 ± 2.3 months2 (50)5050
Cillo et al[64], 2005
1Female, 10 years3 months1 (100)100None
Campos et al[10], 20041Female,16 years5 days0-None